These findings strongly suggest that higher numbers of cells expressing ALDH and CD44 biomarkers are associated with an elevated RhoC expression in HNSCC and hence they can promote and maintain the CSCs in head and neck cancer. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.